GZ4
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans; and dental and vision insurance plans. It also sells medicines. The company was founded in 1989 and is based in Luxembourg, Luxembourg.
GZ4 (GZ4) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.081x
Based on the latest financial reports, GZ4 (GZ4) has a cash flow conversion efficiency ratio of 0.081x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€145.21 Million) by net assets (€1.80 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
GZ4 - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how GZ4's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
GZ4 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of GZ4 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Unicycive Therapeutics Inc
NASDAQ:UNCY
|
-0.159x |
|
CTT Systems AB
ST:CTT
|
-0.019x |
|
Kuo Yang Construction Co Ltd
TW:2505
|
0.035x |
|
China Evergrande Group
F:EV1
|
-0.004x |
|
Qinghai Spring Medicinal Resources Technology Co Ltd
SHG:600381
|
-0.008x |
|
Forest Packaging Group Co Ltd
SHG:605500
|
0.009x |
|
MK Electron Co. Ltd
KQ:033160
|
-0.039x |
|
Qijing Machinery
SHG:603677
|
0.056x |
Annual Cash Flow Conversion Efficiency for GZ4 (2021–2024)
The table below shows the annual cash flow conversion efficiency of GZ4 from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €1.62 Billion | €668.50 Million | 0.412x | +25.65% |
| 2023-12-31 | €1.78 Billion | €582.41 Million | 0.328x | +214.05% |
| 2022-12-31 | €1.56 Billion | €162.64 Million | 0.104x | -68.92% |
| 2021-12-31 | €545.91 Million | €183.34 Million | 0.336x | -- |